TC
TMO icon

Tenere Capital’s Thermo Fisher Scientific TMO Stock Holding History

Tenere Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
+9,127
New +$4.38M 3.63% 13
2024
Q4 		– Sell
-24,668
Closed -$15.3M – 31
2024
Q3 		$15.3M Sell
24,668
-6,421
-21% -$3.8M 4.06% 10
2024
Q2 		$17.2M Buy
31,089
+524
+2% +$300K 5.1% 5
2024
Q1 		$17.8M Sell
30,565
-12,834
-30% -$7.2M 5.29% 5
2023
Q4 		$23M Buy
43,399
+26,931
+164% +$13M 7.53% 2
2023
Q3 		$8.34M Sell
16,468
-2,132
-11% -$1.14M 3.21% 16
2023
Q2 		$9.7M Buy
18,600
+100
+0.5% +$54K 4.76% 6
2023
Q1 		$10.7M Buy
+18,500
New +$10.4M 5.57% 2
2022
Q4 		– Sell
-18,109
Closed -$9.19M – 29
2022
Q3 		$9.19M Sell
18,109
-5,200
-22% -$2.91M 4.47% 11
2022
Q2 		$12.7M Buy
23,309
+1,800
+8% +$991K 5.96% 7
2022
Q1 		$12.7M Buy
21,509
+4,352
+25% +$2.5M 4.87% 9
2021
Q4 		$11.4M Buy
+17,157
New +$10.7M 4.55% 7

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Tenere Capital's TMO Position: Q2 2026 in Review

Tenere Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 9,127 shares worth $4.58M. The stake represents 3.63% of the portfolio and ranks #13 among its holdings. This is a return to the name: Tenere Capital previously reported a position in TMO as recently as Q3 2024.

Tenere Capital first reported a position in TMO in Q4 2021 and has held it in 12 quarters since. The position peaked at $23M in Q4 2023. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Tenere Capital held 9,127 shares of Thermo Fisher Scientific worth $4.58M as of Q2 2026.
  • Thermo Fisher Scientific was a new Tenere Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 3.63% of Tenere Capital's portfolio in Q2 2026, its #13 holding.
  • Tenere Capital first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 12 quarters since.
  • Tenere Capital's Thermo Fisher Scientific position peaked at $23M in Q4 2023.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tenere Capital's 13F filing for Q2 2026, filed 14 Aug 2026.